Fractional derivative method for describing solitons on the surface of deep water

Theoretical and Mathematical Physics - The fractional derivative method is used to take wave dispersion into account in the wave equation when describing the propagation of gravitational soliton...     

Polycrystallinity in Gallium Arsenide Crystals Grown by the Czochralski Method

Crystallography Reports - The specific features of the formation of crystallites in gallium arsenide crystals grown by the Czochralski method have been investigated. The crystallites are found to...     

Biosynthesis of zinc oxide nanoparticles using Euphorbia milii leaf constituents: Characterization and improved photocatalytic degradation of methylene blue dye under natural sunlight

A facile biosynthesis route was followed to prepare zinc oxide nanoparticles (ZnO NPs) using Euphorbia milii (E. milii) leaf constituents. The SEM images exhibited presence of spherical ZnO NPs and the corresponding TEM images disclosed monodisperse nature of the ZnO NPs with diameter ranges between 12 and 20 nm. The Brunauer–Emmett–Teller (BET) analysis revealed that the ZnO NPs have specific surface area of 20.46 m²/g with pore diameter of 2 nm–10 nm and pore volume of 0.908 cm³/g. The EDAX spectrum exemplified the existence of Zn and O elements and non-appearance of impurities that confirmed pristine nature of the ZnO NPs. The XRD pattern indicated crystalline peaks corresponding to hexagonal wurtzite structured ZnO with an average crystallite size of 16.11 nm. The FTIR spectrum displayed strong absorption bands at 512 and 534 cm^?1 related to ZnO. The photocatalytic action of ZnO NPs exhibited noteworthy degradation of methylene blue dye under natural sunlight illumination. The maximum degradation efficiency achieved was 98.17% at an illumination period of 50 min. The reusability study proved considerable photostability of the ZnO NPs during photocatalytic experiments. These findings suggest that the E. milii leaf constituents can be utilized as suitable biological source to synthesis ZnO NPs for photocatalytic applications.     

Methods of Coherent X-Ray Diffraction Imaging

Crystallography Reports - Methods of coherent X-ray diffraction imaging of the spatial structure of noncrystalline objects and nanocrystals (nanostructures) are considered. Particular attention is...     

One-sided invertibility of discrete operators with bounded coefficients

Aequationes mathematicae - For $$p\in (1,\infty )$$ , we establish several criteria of one-sided invertibility on spaces $$l^p=l^p(\mathbb {Z})$$ for discrete band-dominated operators being either...     

Reply to comment on “Limitation of uranium and thorium traces in charnockite matrix‐PIXE analyses at 3 MeV with Si (Li) detector”

Journal of Radioanalytical and Nuclear Chemistry -     

Exact solutions of an asymmetric double well potential

Journal of Mathematical Chemistry - The analytical solutions of an asymmetric double well potential $$V(x)=a\, x^2-b\, x^3+c\, x^4$$ are found to be a triconfluent Heun function $$H_{T}(\alpha ,...     

Optimization of the Ambulance Fleet Location and Relocation

Journal of Applied and Industrial Mathematics - We study the problem of optimal location of the ambulance fleet at the base stations. The objective is to minimize the average waiting time for...     

Pectic Galactan Polysaccharide-Based Gene Delivery System for Targeting Neuroinflammation

Treating neuroinflammation-related injuries and disorders through manipulation of neuroinflammation functions is being heralded as a new therapeutic strategy. In this study, a novel pectic galactan (PG) polysaccharide based gene therapy approach is developed for targeting reactive gliosis in neuroinflammation. Galectin-3 (Gal-3) is a cell protein with a high affinity to β-galactoside sugars and is highly expressed in reactive gliosis. Since PG carries galactans, it can target reactive gliosis via specific carbohydrate interaction between galactan and Gal-3 on the cell membrane, and therefore can be utilized as a carrier for delivering genes to these cells. The carrier is synthesized by modifying quaternary ammonium groups on the PG. The resulting quaternized PG (QPG) is found to form complexes with plasmid DNA with a mean diameter of 100 nm and have the characteristics required for targeted gene therapy. The complexes efficiently condense large amounts of plasmid per particle and successfully bind to Gal-3. The in vivo study shows that the complexes are biocompatible and safe for administration and can selectively transfect reactive glial cells of an induced cortical lesion. The results confirm that this PG-based delivery system is a promising platform for targeting Gal-3 overexpressing neuroinflammation cells for treating neuroinflammation-related injuries and neurodegenerative diseases.